Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107 1986, Staging announcement: FIGO Cancer Committee, Gynecol Oncol, 25, 383, 10.1016/0090-8258(86)90092-2 Omura, 1991, Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience, J Clin Oncol, 9, 1138, 10.1200/JCO.1991.9.7.1138 Thigpen, 1993, Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience, Cancer, 71, 606, 10.1002/cncr.2820710218 Chi, 2001, Identification of prognostic factors in advanced epithelial ovarian carcinoma, Gynecol Oncol, 82, 532, 10.1006/gyno.2001.6328 Clark, 2001, A prognostic model for ovarian cancer, Br J Cancer, 85, 944, 10.1054/bjoc.2001.2030 Zhang, 2003, Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer, N Engl J Med, 348, 203, 10.1056/NEJMoa020177 van Houwelingen, 1989, Predictability of the survival of patients with advanced ovarian cancer, J Clin Oncol, 7, 769, 10.1200/JCO.1989.7.6.769 Marsoni, 1990, Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG), Br J Cancer, 62, 444, 10.1038/bjc.1990.315 Lund, 1990, Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinoma, Cancer Res, 50, 4626 Gallagher, 2010, Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity, Ann Oncol, 22, 1127, 10.1093/annonc/mdq577 Kattan, 2000, Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer, J Clin Oncol, 18, 3352, 10.1200/JCO.2000.18.19.3352 Kattan, 2002, Postoperative nomogram for 12-year sarcoma-specific death, J Clin Oncol, 20, 791, 10.1200/JCO.20.3.791 Kattan, 2003, Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma, J Clin Oncol, 21, 3647, 10.1200/JCO.2003.01.240 Chi, 2008, Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma, Gynecol Oncol, 108, 191, 10.1016/j.ygyno.2007.09.020 Gerestein, 2009, The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma, BJOG, 116, 372, 10.1111/j.1471-0528.2008.02033.x Serov, 1973, Histologic typing of ovarian tumors, 17 Gray, 1988, A class of K-sample tests for comparing the cumulative incidence of a competing risk, Ann Stat, 16, 1141, 10.1214/aos/1176350951 Fine, 1999, A proportional hazards model for the subdistribution of a competing risk, J Am Stat Assoc, 94, 496, 10.1080/01621459.1999.10474144 Wolbers, 2009, Prognostic models with competing risks: methods and application to coronary risk prediction, Epidemiology, 20, 555, 10.1097/EDE.0b013e3181a39056 Harrell, 1996, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors, Stat Med, 15, 361, 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 Vickers, 2006, Decision curve analysis: a novel method for evaluating prediction models, Med Decis Making, 26, 565, 10.1177/0272989X06295361 Teramukai, 2007, PIEPOC: a new prognostic index for advanced epithelial ovarian cancer—Japan Multinational Trial Organization OC01-01, J Clin Oncol, 25, 3302, 10.1200/JCO.2007.11.0114 Clark, 2007, Validation of a new prognostic index for advanced epithelial ovarian cancer: results from its application to a UK-based cohort, J Clin Oncol, 25, 5669, 10.1200/JCO.2007.14.2976